Breast Cancer Trials24 Marras 2020

The First Australian BRCA-P Participants Share Their Story

The First Australian BRCA-P Participants Share Their Stories

Cousins Raylee and Lisa are the first Australian participants in the ground-breaking BRCA-P clinical trial.

The BRCA-P trial is a prevention trial which is testing the effectiveness of a drug called Denosumab in preventing breast cancer in women with a BRCA1 gene mutation, like Lisa and Raylee. This treatment has been fast-tracked from the lab to a stage three clinical trial due to its impressive pre-clinical results.

Listen in as Lisa and Raylee tell us what it's like to know you have a 70% risk of being diagnosed with breast cancer due to the BRCA1 gene mutation, their experiences in participating in the BRCA-P clinical trial, and what their children think about their 50/50 chance of having the BRCA1 gene mutation.

Like this episode? ⁠⁠Follow Breast Cancer Trials on Social Media:

Guests: Raylee and Lisa, the first Australian participants in the ground-breaking BRCA-P clinical trial.

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about clinical trials research.

Find out more: www.breastcancertrials.org.au

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(167)

Hot Flushes, Poor Sleep & More: Managing Menopause After Breast Cancer

Breast cancer treatment can bring on menopause suddenly or make existing symptoms more severe, significantly affecting a woman's quality of life. In this episode, we sit down with Dr Christina Jang to...

30 Syys 7min

What's Next When Treatment for Triple-Negative Breast Cancer Stops Working?

Treatment for triple-negative breast cancer has advanced significantly, but challenges remain when, in some cases, the disease returns after treatment.In this episode, we sit down with Dr Belinda Yeo ...

18 Syys 8min

What Makes Lobular Breast Cancer Different? Unlocking the Biology of Invasive Lobular Carcinoma

Invasive lobular carcinoma is the second most common type of breast cancer, yet there is still much to learn about what makes this disease biologically distinct. In this episode, we sit down with Asso...

8 Syys 5min

Could Patients with Breast Cancer Safely Skip Radiation & the Potential Side Effects? Inside the ROSALIE Clinical Trial

Could Patients with Breast Cancer Safely Skip Radiation & the Potential Side Effects? Inside the ROSALIE Clinical TrialCould skipping radiation after breast-conserving surgery be safe for some patient...

6 Helmi 6min

Neoadjuvant Now: What's Next in Pre-Surgical Breast Cancer Treatment?

Neoadjuvant Now: What's Next in Pre-Surgical Breast Cancer Treatment?More and more breast cancer patients are now receiving treatment before surgery - but what’s next for this approach? In this episod...

7 Marras 20259min

Next Gen Oncology: Insights for Trainees and Early-Career Clinicians

Next Gen Oncology: Insights for Trainees and Early-Career CliniciansAre you a trainee or early career professional in oncology looking to connect, learn, and grow? In this episode, we highlight the Tr...

6 Marras 20258min

Caring for the Caregivers: Preventing Burnout in Oncology

Caring for the Caregivers: Preventing Burnout in OncologyWhat happens when the people caring for everyone else are running on empty? In this episode, we sit down with London-based Professor of psycho-...

6 Marras 202521min

Intimacy and Insight: Sexual Health After Breast Cancer

Intimacy and Insight: Sexual Health After Breast CancerSexual health after breast cancer is a topic too often left in the shadows - yet it profoundly affects quality of life both during and post-diagn...

29 Loka 202510min